Showing results (261-270 of 398) with videos related to

Sort By:
Pageof 40
International Journal of Molecular Sciences|February 25, 2023
Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint InhibitorsJi Hyun Lee, Soohyun Hwang, ByulA Jee, et al.
Biomedicines|July 27, 2022
Clinical Significance of Preoperative Hematological Parameters in Patients with D2-Resected, Node-Positive Stomach CancerJun Su Park, Jeong Il Yu, Do Hoon Lim, et al.
Cancer Research and Treatment|July 13, 2010
Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapyJina Yun, Kyoung-Mee Kim, Seung Tae Kim, et al.
International Journal of Cancer|August 27, 2014
HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapySang Yun Ha, Jeeyun Lee, Jiryeon Jang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 16, 2015
Phase 1b Trial of Biweekly Intravenous Pexa-Vec (JX-594), an Oncolytic and Immunotherapeutic Vaccinia Virus in Colorectal CancerSe Hoon Park, Caroline J Breitbach, Jeeyun Lee, et al.
Cancers|December 31, 2020
Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression AnalysesJun Su Park, Jeong Il Yu, Do Hoon Lim, et al.
The New England Journal of Medicine|October 23, 2023
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial CarcinomaYohann Loriot, Nobuaki Matsubara, Se Hoon Park, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 11, 2022
Ramucirumab plus paclitaxel as a second-line treatment in HER2-positive gastric cancer: subgroup analysis of a nationwide, real-world study in Korea (KCSG-ST19-16)Bum Jun Kim, Hee-Jung Jee, Sun Young Rha, et al.
Anticancer Research|October 2, 2019
Clinical Outcomes and the Role of Adjuvant Concurrent Chemoradiation Therapy in D2-resected LN-positive Young Patients (≤45 Years) With Gastric CancerJeong Il Yu, DO Hoon Lim, Jeeyun Lee, et al.
Cancer Chemotherapy and Pharmacology|October 8, 2008
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancerSeong Yoon Yi, Young Suk Park, Hyo Song Kim, et al.
Pageof 40